Chung JB - Search Results

1

Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.

Lee SH, Yoon SH, Lee HS, Chung MJ, Park JY, Park SW, Song SY, Chung JB, Bang S. Lee SH, et al. Among authors: chung mj, chung jb. Dig Liver Dis. 2016 Apr;48(4):435-40. doi: 10.1016/j.dld.2015.12.006. Epub 2015 Dec 21. Dig Liver Dis. 2016. PMID: 26775128

2

The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.

Bang S, Chung HW, Park SW, Chung JB, Yun M, Lee JD, Song SY. Bang S, et al. Among authors: chung hw, chung jb. J Clin Gastroenterol. 2006 Nov-Dec;40(10):923-9. doi: 10.1097/01.mcg.0000225672.68852.05. J Clin Gastroenterol. 2006. PMID: 17063113

3

Phase II study of cisplatin combined with weekly gemcitabine in the treatment of patients with metastatic pancreatic carcinoma.

Bang S, Jeon TJ, Kim MH, Park JY, Park SW, Chung JB, Song SY. Bang S, et al. Among authors: chung jb. Pancreatology. 2006;6(6):635-41. doi: 10.1159/000097784. Epub 2006 Dec 6. Pancreatology. 2006. PMID: 17159377 Clinical Trial.

4

[Assessment of the definition of early extrahepatic bile duct cancer through the prognosis analysis who had received curative resection].

Kim HJ, Bang S, Park SW, Song SY, Kim KS, Lee WJ, Chung JB. Kim HJ, et al. Among authors: chung jb. Korean J Gastroenterol. 2007 Aug;50(2):101-7. Korean J Gastroenterol. 2007. PMID: 17928753 Korean.

5

Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer.

Kim YJ, Bang S, Park JY, Park SW, Chung JB, Song SY. Kim YJ, et al. Among authors: chung jb. Cancer Chemother Pharmacol. 2009 Feb;63(3):529-33. doi: 10.1007/s00280-008-0822-7. Epub 2008 Sep 3. Cancer Chemother Pharmacol. 2009. PMID: 18766341 Clinical Trial.

6

Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer.

Kim HM, Bang S, Park JY, Seong J, Song SY, Chung JB, Park SW. Kim HM, et al. Among authors: chung jb. Cancer Chemother Pharmacol. 2009 Feb;63(3):535-41. doi: 10.1007/s00280-008-0836-1. Epub 2008 Oct 1. Cancer Chemother Pharmacol. 2009. PMID: 18828020 Clinical Trial.

7

Prognostic value of thymidine phosphorylase expression for pancreatic cancer.

Hong SP, Shin SK, Bang S, Park SW, Chung JB, Lee WJ, Song SY. Hong SP, et al. Among authors: chung jb. Hepatogastroenterology. 2009 Jul-Aug;56(93):1178-82. Hepatogastroenterology. 2009. PMID: 19760965

8

Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer.

Chung MJ, Lee KJ, Bang S, Park SW, Kim KS, Lee WJ, Song SY, Chung JB, Park JY. Chung MJ, et al. Among authors: chung jb. Ann Surg Oncol. 2011 Jun;18(6):1651-6. doi: 10.1245/s10434-010-1529-7. Epub 2011 Jan 6. Ann Surg Oncol. 2011. PMID: 21210227

9

Clinicopathologic features and outcomes of pancreatic cysts during a 12-year period.

Chung JW, Chung MJ, Park JY, Bang S, Song SY, Chung JB, Park SW. Chung JW, et al. Among authors: chung mj, chung jb. Pancreas. 2013 Mar;42(2):230-8. doi: 10.1097/MPA.0b013e31826ae31a. Pancreas. 2013. PMID: 23146922

10

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma.

Lee KJ, Yi SW, Chung MJ, Park SW, Song SY, Chung JB, Park JY. Lee KJ, et al. Among authors: chung mj, chung jb. Yonsei Med J. 2013 May 1;54(3):643-9. doi: 10.3349/ymj.2013.54.3.643. Yonsei Med J. 2013. PMID: 23549809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters